CANNA HEMP X - Trademark Details
Status: 661 - Response After Non-Final Action - Entered
Serial Number
88984136
Word Mark
CANNA HEMP X
Status
661 - Response After Non-Final Action - Entered
Status Date
2022-04-25
Filing Date
2018-11-05
Mark Drawing
4000 - Standard character mark
Typeset
Attorney Name
Law Office Assigned Location Code
M80
Employee Name
BAGLINI, KAREN
Statements
Goods and Services
Dietary supplements, the foregoing products containing hemp seed oil solely derived from Cannabis sativa L with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and the foregoing products containing only naturally-occurring trace levels of CBD, the aforesaid CBD being solely derived from Cannabis sativa L with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis; Dietary supplements, the foregoing products containing hemp seed oil solely derived from Cannabis sativa L with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and the foregoing products containing no CBD; Liquid nutritional supplement, the foregoing products containing hemp seed oil solely derived from Cannabis sativa L with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and the foregoing products containing only naturally-occurring trace levels of CBD, the aforesaid CBD being solely derived from Cannabis sativa L with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis; Liquid nutritional supplement, the foregoing products containing hemp seed oil solely derived from Cannabis sativa L with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and the foregoing products containing no CBD; Medicated lip balm, in the nature of OTC products, the foregoing products containing, as an inactive ingredient, hemp seed oil solely derived from Cannabis sativa L with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and the foregoing products containing, as an inactive ingredient, naturally-occurring trace levels of CBD, the aforesaid CBD being solely derived from Cannabis sativa L with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis; Medicated lip balm, in the nature of OTC products, the foregoing products containing, as an inactive ingredient, hemp seed oil solely derived from Cannabis sativa L with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and the foregoing products containing no CBD; Medicated skin care preparations, namely, creams, lotions, gels, toners, cleaners and peels, in the nature of OTC products, the foregoing products containing, as an inactive ingredient, hemp seed oil solely derived from Cannabis sativa L with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and the foregoing products containing, as an inactive ingredient, naturally-occurring trace levels of CBD, the aforesaid CBD being solely derived from Cannabis sativa L with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis; Medicated skin care preparations, namely, creams, lotions, gels, toners, cleaners and peels, in the nature of OTC products, the foregoing products containing, as an inactive ingredient, hemp seed oil solely derived from Cannabis sativa L with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and the foregoing products containing no CBD; Nutritional supplements in lotion form sold as a component of nutritional skin care products, the foregoing products containing hemp seed oil solely derived from Cannabis sativa L with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and the foregoing products containing only naturally-occurring trace levels of CBD, the aforesaid CBD being solely derived from Cannabis sativa L with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis; Nutritional supplements in lotion form sold as a component of nutritional skin care products, the foregoing products containing hemp seed oil solely derived from Cannabis sativa L with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and the foregoing products containing no CBD; Orally-ingestible medicinal preparations for the mouth to be applied in the form of drops, capsules, tablets and compressed tablets, in the nature of dietary or nutritional supplements, the foregoing products containing hemp seed oil solely derived from Cannabis sativa L with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and the foregoing products containing only naturally-occurring trace levels of CBD, the aforesaid CBD being solely derived from Cannabis sativa L with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis; Orally-ingestible medicinal preparations for the mouth to be applied in the form of drops, capsules, tablets and compressed tablets, in the nature of dietary or nutritional supplements, the foregoing products containing hemp seed oil solely derived from Cannabis sativa L with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and the foregoing products containing no CBD; Medicinal preparations for the mouth to be applied in the form of drops, capsules, tablets and compressed tablets, in the nature of OTC products, the foregoing products containing, as an inactive ingredient, hemp seed oil solely derived from Cannabis sativa L with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and the foregoing products containing, as an inactive ingredient, naturally-occurring trace levels of CBD, the aforesaid CBD being solely derived from Cannabis sativa L with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis; Medicinal preparations for the mouth to be applied in the form of drops, capsules, tablets and compressed tablets, in the nature of OTC products, the foregoing products containing, as an inactive ingredient, hemp seed oil solely derived from Cannabis sativa L with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and the foregoing products containing no CBD
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
005, 006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2018-11-20
Primary Code
005
Current Trademark Owners
Party Name
Party Type
10 - Original Applicant
Legal Entity Type
16 - Limited Liability Company
Address
Please log in with your Justia account to see this address.
Correspondences
Name
Thomas F. Zuber
Address
Please log in with your Justia account to see this address.
Prior Registrations
Relationship Type | Reel Number |
Continuity Parent | 88979268 |
Trademark Events
Event Date | Event Description |
2018-11-08 | NEW APPLICATION ENTERED IN TRAM |
2018-11-09 | TEAS VOLUNTARY AMENDMENT RECEIVED |
2018-11-09 | TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED |
2018-11-20 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
2018-11-25 | ASSIGNED TO EXAMINER |
2019-06-19 | ASSIGNED TO EXAMINER |
2019-06-19 | NON-FINAL ACTION WRITTEN |
2019-06-19 | NON-FINAL ACTION E-MAILED |
2019-06-19 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
2019-08-08 | TEAS WITHDRAWAL OF ATTORNEY RECEIVED |
2019-08-08 | WITHDRAWAL OF ATTORNEY GRANTED |
2019-08-08 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
2019-12-18 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
2019-12-18 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
2019-12-19 | TEAS REQUEST TO DIVIDE RECEIVED |
2019-12-19 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
2020-01-13 | ASSIGNED TO LIE |
2020-01-14 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
2020-01-17 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2020-01-17 | TEAS/EMAIL CORRESPONDENCE ENTERED |
2019-12-19 | DIVISIONAL REQUEST RECEIVED |
2020-01-23 | DIVISIONAL PROCESSING COMPLETE |
2020-01-23 | DIVISIONAL PROCESSING COMPLETE |
2020-02-20 | NON-FINAL ACTION WRITTEN |
2020-02-20 | NON-FINAL ACTION E-MAILED |
2020-02-20 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
2020-08-19 | TEAS REQUEST TO DIVIDE RECEIVED |
2020-08-19 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
2020-08-19 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2020-08-20 | TEAS/EMAIL CORRESPONDENCE ENTERED |
2020-08-19 | DIVISIONAL REQUEST RECEIVED |
2020-08-25 | DIVISIONAL PROCESSING COMPLETE |
2020-10-08 | TEAS REQUEST TO DIVIDE RECEIVED |
2020-10-08 | TEAS VOLUNTARY AMENDMENT RECEIVED |
2020-10-08 | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED |
2020-10-08 | DIVISIONAL REQUEST RECEIVED |
2020-10-14 | DIVISIONAL PROCESSING COMPLETE |
2020-11-12 | NON-FINAL ACTION WRITTEN |
2020-11-12 | NON-FINAL ACTION E-MAILED |
2020-11-12 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
2021-02-23 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
2021-02-23 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
2021-02-23 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
2021-02-23 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
2021-02-23 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
2021-05-10 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
2021-05-10 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2021-05-11 | TEAS/EMAIL CORRESPONDENCE ENTERED |
2021-05-24 | ASSIGNED TO EXAMINER |
2021-10-13 | ASSIGNED TO EXAMINER |
2021-10-21 | NON-FINAL ACTION WRITTEN |
2021-10-21 | NON-FINAL ACTION E-MAILED |
2021-10-21 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
2022-04-20 | TEAS REQUEST TO DIVIDE RECEIVED |
2022-04-20 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
2022-04-20 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2022-04-25 | TEAS/EMAIL CORRESPONDENCE ENTERED |
2022-04-20 | DIVISIONAL REQUEST RECEIVED |
2022-04-25 | DIVISIONAL PROCESSING COMPLETE |